LambdaVision, Inc.

09/01/2026

We’re expanding our microgravity research!

LambdaVision is partnering with Helogen Corporation for an October mission that will mark our first flight beyond the ISS.

Using Helogen’s autonomous orbital platform, we’ll study bacteriorhodopsin, the light-activated protein used in our artificial retina and gather new data to inform future work in microgravity.

Building on nine missions to the ISS, this is an important next step as we explore new platforms for research and future commercial operations in low-Earth orbit.

Learn more: https://www.lambdavision.com/lambdavision-advances-space-based-manufacturing-with-its-first-mission-beyond-the-iss/

08/28/2026

Space-based biomanufacturing is moving closer to commercial reality, and LambdaVision is part of the story.

We’re proud to see LambdaVision and CEO Nicole Wagner, Ph.D., featured alongside leaders across the industry. The article highlights our nine missions to the International Space Station National Laboratory, the advantages we’ve observed manufacturing our artificial retinas in microgravity, and our plans to expand to new orbital platforms.

Thank you to Michael Greshko for taking a closer look at the opportunities, and challenges, shaping this emerging industry.

Read more: https://www.science.org/content/article/dreams-making-drugs-and-tissues-space-get-closer-reality

Maturing techniques and cheaper launches fuel microgravity research—and hopes of orbital manufacturing

08/17/2026

August is National Eye Exam Month.

Many eye diseases develop without noticeable symptoms, making routine eye exams an important part of protecting your long-term vision.

This month, make your eye health a priority by scheduling a comprehensive eye exam.

07/01/2026

July is Eye Injury Prevention Month!

Summer activities like mowing the lawn, playing sports, fishing, boating, and watching fireworks can increase the risk of eye injuries.

The good news? Many eye injuries are preventable with proper protective eyewear and a few simple safety measures.

At LambdaVision, we are working to develop a protein-based artificial retina for patients affected by retinal degenerative diseases, but protecting healthy vision remains just as important.

This month, make eye safety part of your summer routine and help keep your vision protected for years to come.

Learn more about our mission to restore meaningful vision: https://www.lambdavision.com/

06/23/2026

Happy International Women in Engineering Day from Team LambdaVision!

We are proud to recognize the women engineers and researchers driving innovation across biotechnology and space-based manufacturing. From advancing artificial retina development to pioneering new microgravity manufacturing techniques, their work is helping create solutions that could transform lives.

Thank you to the women helping build the future of science, engineering, and healthcare.

05/18/2026

NEWS: LambdaVision is partnering with Helogen Corporation to advance the future of scalable biomaterial manufacturing in low-Earth orbit.



This mission will mark LambdaVision’s first planned flight outside of the International Space Station and represents an important next step toward regulated, scalable production of our protein-based artificial retina in space.



Through 9 missions to the ISS, LambdaVision has demonstrated the feasibility of manufacturing 200-layer protein thin films in microgravity, where reduced gravity improves homogeneity, stability, and performance.



The collaboration with Helogen grew out of conversations initiated through Boryung’s Humans in Space challenge in 2023, highlighting the importance of building a global ecosystem to advance space-enabled healthcare and biotechnology innovation.



Read the full announcement: https://www.lambdavision.com/lambdavision-and-helogen-partner-to-advance-space-based-biomaterial-manufacturing/

05/11/2026

Healthy Vision Month is a time to prioritize eye health and raise awareness about vision loss affecting millions worldwide.

At LambdaVision, we are working to restore meaningful vision for patients living with retinal degenerative diseases like retinitis pigmentosa and age-related macular degeneration, conditions that impact over 50 million people globally.



We’re working on developing our protein-based artificial retina designed to replace the function of damaged photoreceptor cells, offering a new path forward for those facing blindness.



As we continue advancing this technology, including manufacturing breakthroughs enabled by microgravity, we remain committed to transforming what’s possible for vision care.



Learn more about protecting your vision this month: https://www.nei.nih.gov/about/education-and-outreach/healthy-vision-resources/healthy-vision-month

04/08/2026

This World Health Day, we’re celebrating the theme “Together for health. Stand with science.”



Scientific collaboration is at the heart of better health outcomes around the world. From groundbreaking research to innovative technologies, science helps turn possibility into progress.



At LambdaVision, we’re proud to contribute by developing our protein-based artificial retina in microgravity, working toward restoring vision for patients with retinal degenerative diseases.



Join us in recognizing the power of science to improve lives and build a healthier future for all.



Learn more: https://www.who.int/news-room/events/detail/2026/04/07/default-calendar/world-health-day-2026-together-for-health-stand-with-science